May is Brain Tumor Awareness Month
Melanoma cells are one of the most common cancers that can migrate to the brain, creating a new challenge for patients after their initial round of cancer treatment....
Melanoma cells are one of the most common cancers that can migrate to the brain, creating a new challenge for patients after their initial round of cancer treatment....
Guest blog post by Andree and Joe Leonelli: “Imagine being told your melanoma had returned, three weeks before your wedding. In addition to the natural stresses lea...
Washington, DC (April 26, 2024)– The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program,...
New England, MA (April 18, 2024)– The Melanoma Research Foundation (MRF) is thrilled to announce one of the first events in its annual Miles for Melanoma nationwide 5...
Memphis, TN (April 18, 2024)– The Melanoma Research Foundation (MRF) is thrilled to announce that 2023 Miss Tennessee, Brandee Mills, will be the event emcee for the ...
Guest blog post by Addison, melanoma thriver and MRF supporter: “My melanoma journey began with a mole removal and Stage 1B diagnosis at age 21. Luckily, it was cau...
Guest blog post by Elaine Sisk, melanoma thriver and MRF supporter: “My name is Elaine Sisk and I am a 6+ year survivor of advanced stage IV metastatic melanoma. My i...
As we continue to recognize Women’s History Month, please join us in celebrating our 2021 MRF Career Development Award Grant Recipient, Brittani Seynnaeve, MD, MS. Ch...
As we continue to recognize Women’s History Month, please join us in celebrating our 2022 Medical Student Grant Recipient, Lauren Clai Morehead, PhD. Medical student ...
Guest blog post by Kasey L. Couts, PhD, Assistant Professor, Co-Director, CU Center for Rare Melanomas, Assistant Director, CU Skin Cancer Biorepository at University of Co...
As we recognize Women’s History Month, please join us in celebrating our 2019 Vision of Hope Award Recipient, Marlana M. Orloff, MD. Associate Professor, Department o...
On February 16 the FDA announced the approval of TIL therapy or AMTAGVI™ the first cellular therapy indicated for the treatment of adult patients with cutaneous (skin) me...
Nov 22, 2025 PT